Mucosal Healing with Anti-TNF Antibodies.

Détails

ID Serval
serval:BIB_38B70FC7C0D8
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Mucosal Healing with Anti-TNF Antibodies.
Périodique
Digestion
Auteur(s)
Chevaux J.B., Vavricka S.R., Rogler G., Lakatos P.L., Schoepfer A., Peyrin-Biroulet L.
ISSN
1421-9867 (Electronic)
ISSN-L
0012-2823
Statut éditorial
Publié
Date de publication
2012
Volume
86 Suppl 1
Pages
16-22
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: ppublish
Résumé
Nowadays, mucosal healing is regarded as a major end point in clinical trials and is increasingly used in clinical practice for the management of patients with inflammatory bowel disease. The definition of mucosal healing varies across studies and validated endoscopic scoring indices are still lacking. The advent of anti-tumor necrosis factor agents has changed the way of treating inflammatory bowel disease and high rates of induction and maintenance of mucosal healing can be achieved with this drug class. Mucosal healing is desirable as it may change the natural course of the disease by decreasing surgery and hospitalization rates in both ulcerative colitis and Crohn's disease.
Pubmed
Web of science
Création de la notice
08/11/2012 19:30
Dernière modification de la notice
20/08/2019 14:28
Données d'usage